Loading compare…
3 funds hold both · as on Oct 2025
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 3 mutual funds hold active equity positions in both eMudhra and Sanofi India. The scheme with the highest combined exposure is Nippon India Innovation Fund (Nippon India MF), which holds a 2.61% stake in eMudhra and a 1.90% stake in Sanofi India, amounting to a combined conviction weight of 4.51%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | eMudhra wt. | Sanofi wt. | Combined |
|---|---|---|---|
| Nippon India Innovation FundNippon India MF · Sectoral / Thematic | 2.61% | 1.90% | |
| Nippon India Small Cap FundNippon India MF · Small Cap | 0.75% | 0.35% | |
| IB18-Groww Nifty Total Market Index FundGroww MF · Index Fund | 0.01% | 0.02% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Oct 2025). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.